Top Five Companies Account for 35% Share of the Overall Hormone Replacement Therapy Market
The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players.
Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market.
Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and Bayer AG collectively – collectively account for 35 percent revenue share of the hormone replacement therapy market from on the global front.
Tier 1 hormone replacement therapy companies are focused on carrying out clinical trials for new product development (NPD). Moreover, these companies are adopting vertical, horizontal and backward integration in a bid to achieve rapid expansion and pace in technological development.
In addition, tier 1 hormone replacement therapy companies are forming alliances to co-develop and commercialize hormone replacement therapy drugs.
For instance, Pfizer Inc., and Merck KGaA have formed a strategic alliance to develop avelumab (BAVENCIO) to manage hypothyroidism and other thyroid disorders.
Agreement between FDA and NASEM to Impact Hormone Replacement Therapy Market Growth
Food and Drug Administration (FDA) has signed an agreement with NASEM (National Academies of Science, Engineering & Medicine) and is carrying out expanded agreements with University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation.
Main focus behind this initiative was to conduct research and inform consumers regarding compounded drugs.
NASEM is examining the utility of treating individuals with compounded BHRT (Bioidentical Hormone Replacement Therapy) products.
Compounded Bioidentical hormone replacement therapy products such as testosterone and progesterone are used instead of FDA approved hormone replacement therapy drugs as BHRT drugs are considered more safe and natural for patients.
This factor is likely to impact the clinical trials of new hormone replacement therapy products in turn challenging the growth of hormone replacement therapy market.
Know More Details About the Report
Use of Low Cost Generic Versions of Hormone Replacement Therapy Drugs – An Upcoming Trend
Affordability has always remained a major challenge for any pharmaceutical drug or formulation. Moreover, insufficient healthcare reimbursements have resulted in individuals opting for cheaper drugs with unclear drug effectiveness.
This prompted manufactures of hormone replacement therapy drugs to produce generic versions of the formulations in a bid to bridge the gap between purchasing power of people and hormone replacement therapy drug pricing.
Companies developing generic hormone replacement therapy drugs are also acquiring FDA approvals, which is direct inference apropos to drug effectiveness.
For instance, Teva pharmaceuticals has introduced generic version of Estrace cream and estradiol vaginal cream in 2018. The trend is expected to auger well for the overall growth of the hormone replacement therapy market.
Rising Prevalence of Osteoporosis to Influence Hormone Replacement Therapy Demand
Growing life expectancy is closely associated with degeneration that further translates into osteoporotic fractures. In addition, this condition further results in an increase in gap between spine bones during menopause with diminishing estrogen levels.
According to the International Osteoporosis Foundation, osteoporosis causes over 8.9 million fractures annually on the global front and is likely to grow in the coming years.
Rising prevalence of osteoporosis among women is expected to trigger the demand for hormone replacement therapy.
Avail customized purchase options for your needs
Hormone Replacement Therapy Associated with Reduced Dementia – Key Growth Propellant
Hormone replacement therapy can protect memory which is required to carry out short-term cognitive tasks after menopausal stress.
Estrogen-only hormone replacement therapy can facilitate lower stress levels without impacting memory. In addition, hormone replacement therapy also reduces possibilities of both vascular dementia and Alzheimer’s disease.
Combination Hormone Replacement Therapy Associated with Cancer – Key Growth Deterrent
Use of hormone replacement therapy can lead to cancerous cell development. The use of combination hormone replacement therapy (combination of progesterone and estrogen) can increase the risk of breast cancer by 75 percent even if used for a short timeframe.
According to the U.S Women’s Health Initiative, the use of combination hormone replacement therapy comes with the risk of development of several cancers including ovarian and uterus cancers.
This aspect is expected to confine the growth in adoption of hormone replacement therapy in the forthcoming years.
Other hormone replacement therapy related disorders such as stroke, cardiac disorders and blood clots are further expected to negatively impact the growth of the hormone replacement therapy market.
An Adaptive Approach to Modern-day Research Needs
The report on hormone replacement therapy market offers intelligence on key participants in the hormone replacement therapy market.
The key companies involved in the formulation of hormone replacement therapy products are thoroughly assessed and profiled in the report.
Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include
- Novartis AG
- Novo Nordisk A/S
- Teva Pharmaceuticals
- Mylan N.V and Pfizer Inc.
Major companies in the hormone replacement therapy market are concentrating on expanding their current product portfolio. New hormone replacement therapy formulations being the core focus, companies are carrying out trials and gain FDA approvals.
For instance, Novartis AG’s research and development department delivered 6 critical FDA breakthrough therapy designations and 16 submissions in 2017. In May 2017, Novartis AG announced U.S. FDA’s approval for its hormone replacement therapy tablets for hormone receptor positive and metastatic breast cancer treatment in postmenopausal women.
In February 2018, Novo Nordisk A/S concluded main phase of REAL 1 – the pivotal phase 3 trial along with somapacitan, a long-acting growth hormone to treat adults with growth hormone deficiency.
Teva Pharmaceuticals Industries Ltd. introduced Vagifem in 2017 for the treatment of atrophic vaginitis. In January 2018, the company launched Estrace cream to treat moderate and severe symptoms of vaginal and vulgar atrophy occurring due to menopause.
Likewise, Mylan N.V expanded its US portfolio in the women’s healthcare range with U.S. FDA approval for Estradiol Vaginal Cream to treat vaginal atrophy.
Private equity firms are focused on acquiring emerging participants that are involved in drug delivery systems in the hormone replacement therapy space.
For instance, Riverside Company has acquired DoseLogix in a bid to provide innovative dosing dispensers for ensuring accurate dosing medications of hormone replacement therapy and other conditions.
Hormone replacement therapy, also referred to as menopausal hormone therapy, is used to treat various symptoms related to menopause among women. Hormone replacement therapy replaces hormones that are low in level as women near menopause.
There are various types of hormone replacement therapy such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy.
Have a report related query? Speak to us directly
About the Report
The report on hormone replacement therapy market provides incisive insights on all aspects influencing growth in demand for hormone replacement therapy worldwide.
The report provides a thorough analysis on demand of hormone replacement therapy across key regions in the globe along with sales of various hormone replacement therapy products.
Key drivers, challenges, trends and opportunities shaping the growth of the hormone replacement therapy market are also covered in the hormone replacement therapy market report.
The hormone replacement therapy market report provides historical data assessment on use of hormone replacement therapy, current hormone replacement therapy scenario and future demand of hormone replacement therapy. The forecast projections provided cover a timeline of 10 years (2018-2028).
The hormone replacement therapy market is segmented in detail to cover every angle of the hormone replacement therapy space.
The hormone replacement therapy market has been segmented on the basis of product type, by dosage form, by indication, by distribution channel and by region.
Various hormone replacement therapy products such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is covered.
By dosage form, hormone replacement therapy market is segmented into tablets, patches, injections, implants and creams.
By indications, hormone replacement therapy market is categorized into menopause, osteoporosis, thyroid and growth hormone deficiency.
By distribution channel, it is segmented by hospital pharmacies, clinics, retail pharmacies and online pharmacies.
The hormone replacement therapy market is assessed across key regions such as North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Middle East and Africa (MEA) and Japan.
Additional Questions Answered
Apart from key findings mentioned above, the hormone replacement therapy market report also answers additional questions such as:
- Which is the most attractive regional market for hormone replacement therapy?
- Which dosage form is largely preferred for using hormone replacement therapy worldwide?
- Due to which indication is the hormone replacement therapy market is witnessing a significant upswing in demand?
- Which country in the APEJ region accounts for a higher market share in the APEJ hormone replacement therapy?
- Which is the most lucrative hormone replacement therapy distribution channel?
The hormone replacement therapy market is drafted using a unique research methodology comprising of a combination of secondary and primary research methodologies.
The data gleaned from primary and secondary research is assessed along with information from external sources. All the statistics are compiled using triangulation method to gain highly accurate projections on hormone replacement therapy market.
Hormone Replacement Therapy Market Scope Of The Report
The “hormone replacement therapy market forecast, trend analysis and competition tracking – global market insights, 2018-2028” report is an exclusive study revealing several facets of hormone replacement therapy market.
The hormone replacement therapy market report includes forecast projections for a period of 10 years, form 2018 to 2028.
The hormone replacement therapy market study also includes various aspects impacting the demand and sales of various hormone replacement therapy products worldwide along with a year-on-year growth assessment of hormone replacement therapy.
Historical data on hormone replacement therapy adoption, current hormone replacement therapy scenario and future projections on hormone replacement therapy market are provided in the hormone replacement therapy market report.
Chapter 1 – Executive Summary
The executive summary of hormone replacement therapy market report provides over view of the hormone replacement therapy market along with critical market analysis, analyst recommendations, and wheel of fortune revealing opportunity assessment.
Chapter 2 – Market Introduction
This chapter in the hormone replacement therapy market report covers definition of the hormone replacement therapy market. It also includes detailed segmentation of hormone replacement therapy market along with scope of research.
Chapter 3 – Market Dynamics
This vast chapter covers analysis on various aspects impacting the demand for hormone replacement therapy.
Various drivers, trends, restraints or challenges and opportunities in the hormone replacement therapy market influencing sales of hormone replacement therapy drugs or formulations worldwide are included in this chapter.
Chapter 4 – Associate Industry Dynamics
This chapter in the hormone replacement therapy market report mainly focuses on key regulations circling the hormone replacement therapy space.
Political, economic, social, technological and environmental (PESTLE) analysis is also provided in this chapter. It also covers average selling prices of hormone replacement therapy across every country.
Chapter 5 – Key Inclusions
This chapter includes patient journey in hormone replacement therapy (HRT), treatment preference of physicians and top brands prescribed across every country.
Chapter 6 – Hormone Replacement Therapy Market Analysis
This chapter provides the overall hormone replacement therapy market outlook. It includes overall market valuation and forecast analysis along with regional demand assessment.
Chapter 7 – Hormone Replacement Therapy Market by Therapy Type
This chapter in the hormone replacement therapy market report includes a year-on-year assessment on various therapy types in the hormone replacement therapy market. Analysis on various types such as estrogen hormone replacement therapy, thyroid hormone replacement therapy and growth hormone replacement therapy is provided in the chapter.
Chapter 8 – Hormone Replacement Therapy Market by Dosage Form
Assessment on various dosage forms facilitating administration of hormone replacement therapy drugs is covered here.
The chapter includes analysis on demand projections of various hormone replacement therapy dosage forms including tablets, patches, implants, creams and injection.
Chapter 9 – Hormone Replacement Therapy Market by Disease Indications
This chapter in the hormone replacement therapy market report includes thorough analysis on disease indications of hormone replacement therapy such as menopause, osteoporosis, thyroid and growth hormone deficiency.
Chapter 10 – Hormone Replacement Therapy Market by Distribution Channel
This chapter in the hormone replacement therapy market report includes intelligence on the most attractive distribution channel for hormone replacement therapy.
Market attractiveness of each channel including hospital pharmacies, retail pharmacies, clinics and online pharmacies is provided here.
Chapter 11 – North America Hormone Replacement Therapy Market
This chapter covers a country wise assessment on use of hormone replacement therapy in North America region.
Key countries of United States and Canada are covered. Hormone replacement therapy market segmental outlook across these countries is provided here.
Chapter 12 – Latin America Hormone Replacement Therapy Market
Key countries in Latin America such as Brazil and Mexico are assessed.
Demand for hormone replacement therapy across these countries is analyzed and sales of various hormone replacement therapy products in the region are sketched in the chapter.
Chapter 13 – Europe Hormone Replacement Therapy Market
European business outlook apropos to hormone replacement therapy market along with country wise assessment is provided in this chapter.
Countries such as Germany, United Kingdom, France, Spain, Russia and Italy are included wherein individual hormone replacement therapy market analysis is carried out across these geographies.
Chapter 14 – Asia Pacific Excluding Japan (APEJ) Hormone Replacement Therapy Market
This extensive chapter in the hormone replacement therapy market report includes assessment of adoption and use of hormone replacement therapy across countries such as India, China, Australia and rest of APEJ.
Value share analysis of hormone replacement therapy market and lucrativeness of APEJ in the hormone replacement therapy marketplace is highlighted in the chapter.
Chapter 15 – Japan Hormone Replacement Therapy Market
Segmental snapshot of hormone replacement therapy market across the country is provided in this chapter. In addition, business outlook in Japan in the hormone replacement therapy space along with key aspects influencing growth are covered in the chapter.
Chapter 16 – Middle East and Africa (MEA) Hormone Replacement Therapy Market
Business outlook of hormone replacement therapy market across Africa, GCC countries, and rest of MEA is provided in the report.
Various aspects impacting the growth of MEA hormone replacement therapy market are also included here.
Overall attractiveness of MEA hormone replacement therapy market is provided that can be used as an indicator from investment standpoint.
Chapter 17 – Competition Landscape
This crucial chapter in the hormone replacement therapy market report provides a competitive dashboard, industry structure and market shares of companies and includes profiles of key participants in the hormone replacement therapy market.
Chapter 18 – Assumptions and Acronyms Used
This chapter in the hormone replacement therapy market report reveals all assumptions taken into consideration while drafting the report.
For instance, all values being represented in US$ Mn and CAGR in percentage. It also includes various acronyms used in the report throughout.
Chapter 19 – Research Methodology
The chapter in the hormone replacement therapy market report reveals the methodology adopted for gleaning key insights on hormone replacement therapy market.
Data from primary, secondary and external sources such as SEC filings, company press releases, newspapers, company annual reports, and literature from regulatory authorities such as WHO and NHI is gathered and triangulated to obtain highly realistic and accurate hormone replacement therapy statistics.
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.